These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10501279)

  • 1. Hyperlipidaemia management after primary coronary artery bypass surgery: a survey of patients and general practitioners.
    Goldsmith I; Lip GY; Emsden K; Nugent A; Patel RL
    J Cardiovasc Risk; 1999 Aug; 6(4):263-7. PubMed ID: 10501279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation.
    Bairey Merz CN; Felando MN; Klein J
    J Cardiopulm Rehabil; 1996; 16(2):117-22. PubMed ID: 8681156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease.
    Carlsen SM; Rossvoll O; Bjerve KS; Følling I
    J Intern Med; 1996 Mar; 239(3):227-33. PubMed ID: 8772621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit.
    Northridge DB; Shandall A; Rees A; Buchalter MB
    Br Heart J; 1994 Nov; 72(5):466-7. PubMed ID: 7818965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observed changes in the lipid profile and calculated coronary risk in patients given dietary advice in primary care.
    Price D; Ramachandran S; Knight T; Jones PW; Neary RH
    Br J Gen Pract; 2000 Sep; 50(458):712-5. PubMed ID: 11050787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.
    Sdringola S; Nakagawa K; Nakagawa Y; Yusuf SW; Boccalandro F; Mullani N; Haynie M; Hess MJ; Gould KL
    J Am Coll Cardiol; 2003 Jan; 41(2):263-72. PubMed ID: 12535820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary advice for patients undergoing coronary artery bypass surgery: falling on deaf ears?
    Hartwell D; Henry J
    Int J Food Sci Nutr; 2003 Jan; 54(1):37-47. PubMed ID: 12701236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering for prevention of coronary heart disease: what policy now?
    Ul Haq I; Ramsay LE; Pickin DM; Yeo WW; Jackson PR; Payne JN
    Clin Sci (Lond); 1996 Oct; 91(4):399-413. PubMed ID: 8983865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes and practice of New Zealand doctors in the management of patients with dyslipidaemia.
    Bradley A; Elliott J; White H
    N Z Med J; 1993 Jun; 106(958):243-7. PubMed ID: 8332291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has interest in secondary prevention increased among physicians after the 4S study?
    Attebring MF; Hartford M; Berndt AK; Herlitz J
    Scand Cardiovasc J; 2000; 34(2):164-7. PubMed ID: 10872703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor control five years after coronary bypass grafting.
    Skinner JS; Farrer M; Albers CJ; Adams PC
    J R Coll Physicians Lond; 1996; 30(2):136-41. PubMed ID: 8709060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting.
    Novaro GM; Pearce GL; Sprecher DL; Griffin BP
    J Heart Valve Dis; 2001 Jan; 10(1):19-24. PubMed ID: 11206763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study.
    Lindholm LH; Ekbom T; Dash C; Isacsson A; Scherstén B
    J Intern Med; 1996 Jul; 240(1):13-22. PubMed ID: 8708586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.
    Frick MH; Syvänne M; Nieminen MS; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Taskinen MR
    Circulation; 1997 Oct; 96(7):2137-43. PubMed ID: 9337181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.
    Nikkilä EA; Viikinkoski P; Valle M; Frick MH
    Br Med J (Clin Res Ed); 1984 Jul; 289(6439):220-3. PubMed ID: 6430414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive family history of coronary atherosclerosis and serum triglycerides may predict repeated coronary artery bypass surgery.
    Mennander A; Angervuori T; Huhtala H; Karhunen P; Tarkka M; Kuukasjärvi P
    Scand Cardiovasc J; 2005 Sep; 39(4):225-8. PubMed ID: 16118070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of serum lipoproteins after coronary artery bypass surgery.
    Shaukat N; Ashraf SS; Mackness MI; Mbewu AD; Bhatnagar D; Durrington PN
    QJM; 1994 Sep; 87(9):539-45. PubMed ID: 7953502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prompt impact of first prospective statin mega-trials on postoperative lipid management of CABG patients: a 20-year follow-up in a single hospital.
    Palomäki A; Hällberg V; Ala-Korpela M; Kovanen PT; Malminiemi K
    Lipids Health Dis; 2016 Jul; 15(1):124. PubMed ID: 27460359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.